维普中文期刊产品整合服务
390篇 您的检索式:作者名="Voor"
    题名 作者 年代 出处 被引量
1Tumor lysis syndrome: A clinical review显示文摘Tumor lysis syndrome is an oncometabolic emergency resulting from rapid cell death. Tumor lysis syndrome can occur as a consequence of tumor targeted therapy or spontaneously. Clinicians should stratify every hospitalized cancer patient and especially those receiving chemotherapy for the risk of tumor lysis syndrome. Several aspects of prevention include adequate hydration, use of uric acid lowering therapies, use of phosphate binders and minimization of potassium intake. Patients at high risk for the development of tumor lysis syndrome should be monitored in the intensive care unit. Established tumor lysis syndrome should be treated in the intensive care unit by aggressive hydration, possible use of loop diuretics, possible use of phosphate binders,use of uric acid lowering agents and dialysis in refractory cases.Aibek E Mirrakhimov Prakruthi Voore Maliha Khan Alaa M Ali 2015World Journal of Critical Care Medicine2015,4,2:5
2慢性心力衰竭新的药物治疗策略显示文摘就发生率、流行率、发病率、死亡率及医疗费用而言,心力衰竭(HF)仍然是公共重要的医疗健康问题,尽管采用了最佳药物治疗,死亡率仍极高,因慢性心力衰竭(CHF)恶化住院患者4年死亡率高达60%。最初HF的治疗目的主要是改善症状,近10年治疗模式已转变为改善疾病的过程和延长患者生命。利尿剂、血管紧张素转换酶抑制剂(ACEI)、β阻滞剂、地高辛和非选择性醛固酮拮抗剂以及近来的血管紧张素受体拮抗剂(ARB)已被证实为CHF有效的治疗方法。随着对CHF病理生理的进一步了解,Wal RMA Voors AA Plokker HWM 张纪良(节译) 曾朝荣(校) 2006心血管病学进展2006,27,2:4
3The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial显示文摘Scott D Solomon Michael Zile Burkert Pieske Adriaan Voors Amil Shah Elisabeth Kraigher-Krainer Victor Shi Toni Bransford Madoka Takeuchi Jianjian Gong Martin Lefkowitz Milton Packer John JV McMurray 20122012 (9851)2012,,9851:3
4慢性心力衰竭时的贫血不仅与肾脏灌注受损和促红细胞生成素减少有关,亦与液体潴留有关显示文摘目的:贫血在慢性心力衰竭(CHF)人群中普遍,但其原因尚不明确。本研究旨在观察CHF患者中贫血与肾脏灌注、促红细胞生成素(EPO)生成及液体潴留之间的关系。方法和结果:作者观察了97例CHF患者,其中15例伴有贫血(男性Hb〈130g/L,女性Hb〈120g/L),但无补血剂缺乏。分别用连续灌注^125I-碘酞酸盐的清除率和分布容积来检测肾小球滤过率(GFR)和细胞外容积(ECV)。有效肾血浆流量(ERPF)则依据^131I-邻碘马尿酸钠的清除率确定。贫血的CHF患者表现出显著降低的GFR、ERPF和EPO生成(分别为P=0.002、P=0.005和P=0.001),以及增加的ECV(P=0.015)。Westenbrink B.D. Visser F.W. Voors A.A. 孙凯 2007世界核心医学期刊文摘(心脏病学分册)2007,3,7:3
5The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial显示文摘Scott D Solomon Michael Zile Burkert Pieske Adriaan Voors Amil Shah Elisabeth Kraigher-Krainer Victor Shi Toni Bransford Madoka Takeuchi Jianjian Gong Martin Lefkowitz Milton Packer John JV McMurray 2012The Lancet2012,,9851:2
6Iron deficiency in chronic heart failure: An international pooled analysis显示文摘IJsbrand T. Klip Josep Comin-Colet Adriaan A. Voors Piotr Ponikowski Cristina Enjuanes Waldemar Banasiak Dirk J. Lok Piotr Rosentryt Ainhoa Torrens Lech Polonski Dirk J. van Veldhuisen Peter van der Meer Ewa A. Jankowska 2013American Heart Journal2013,,:2
7Characterization of intercellular adhesion molecular-1 and HLA-DR expression in normal and inflamed skin:modulation by recombinant interferon and tumor necrosis factor显示文摘Griffths CEM voor Hees JJ Nickoloff BJ 1989J Am Acad Dermatol1989,20,4:2
8Erythropoietin in cardiovascular diseases 显示文摘Van der Meera P Voors AA Lipsie E 2004Europ Heart J2004,25,:1
9Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial显示文摘John R Teerlink Gad Cotter Beth A Davison G Michael Felker Gerasimos Filippatos Barry H Greenberg Piotr Ponikowski Elaine Unemori Adriaan A Voors Kirkwood F Adams Maria I Dorobantu Liliana R Grinfeld Guillaume Jondeau Alon Marmor Josep Masip Peter S Pang 2013The Lancet . 2013 (9860)2013,,9860:1
10With- drawal ofa novel - design duodenoscope ends outbreak of a VIM - 2 - producing Pseudomonas aeruginosa 显示文摘Verfaillie C J Bruno M J F Voor In I Hoh A el al 2015Endosco-gy2015,47,6:1
11Mechanical study of the safe distance between distal femoral fracture site and distal locking screws in an-tegrade intramedullary nailing 显示文摘Antekeier SB Burden RL Jr Voor MJ 2005J Orthop Trauma2005,1919,10:1
12Mild preoperative renal dysfunction as a predictor of long-term clinical outcome after coronary bypass surgery显示文摘van de Wal RMA van Brussel BL Voors AA 2005J Thorac Cardiovasc Surg2005,29,2:1
13Incremental Prognostic Power of Novel Biomarkers (Growth-Differentiation Factor-15, High-Sensitivity C-Reactive Protein, Galectin-3, and High-Sensitivity Troponin-T) in Patients With Advanced Chronic Heart Failure显示文摘Dirk J. Lok IJsbrand T. Klip Sjoukje I. Lok Pieta W. Bruggink-André de la Porte Erik Badings Jan van Wijngaarden Adriaan A. Voors Rudolf A. de Boer Dirk J. van Veldhuisen Peter van der Meer 2013The American Journal of Cardiology2013,,:1
142016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for thediagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC显示文摘Ponikowski P Voors AA Anker SD el al 2016Eur Heart j2016,37,27:1
15Prognostic importance of renal function in patients with early heart failure and mild left ventricular dysfunction显示文摘 Hilleqe HE Voors AA 2004Am J Cardiol2004,94,2:1
16Statins in the treatment of chronic heart failure:biolocal and clinical considerations 显示文摘VAN DER HARST P VOORS A A VAN GILST W H 2006Cardiovasc Res2006,71,3:1
17Prevalence,incidence,andprognostic value of anaemia in patients after an acute myocardialinfarction:data from the OPTIMAAL trial显示文摘Anker SD Voors A Okonko D et a1 2009Eur Heart J2009,30,11:1
18Mechanical study of the safe distance between distal femoral fracture site and distallocking screws in antegrade intramedullary nailing显示文摘Antekeier SB Burden RL Jr Voor MJ et a1 2005Orthop Trauma2005,19,10:1
19Increased peak contact stress after incongruent reduction of transverse acetabular fractures:a cadaretie model显示文摘Malkani AL Voor MJ Rennirt G 2001J Trauma2001,4,:1
20Blood pressure in children and factors predisposing to hypertensive disease in adults显示文摘Bereson GS Voors AW Webber LS 1981Pediatric Cardiology1981,,4:1
返回顶部 每页显示:
共20页 首页 上一页 第1页 下一页 末页 /20 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费